Literature DB >> 26975991

The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans.

Jacob G Ludington1, Honorine D Ward2,3.   

Abstract

The apicomplexan parasite Cryptosporidium causes significant diarrheal disease worldwide. Effective anticryptosporidial agents are lacking, in part because the molecular mechanisms underlying Cryptosporidium-host cell interactions are poorly understood. Previously, we identified and characterized a novel Cryptosporidium parvum C-type lectin domain-containing mucin-like glycoprotein, CpClec. In this study, we evaluated the mechanisms underlying interactions of CpClec with intestinal epithelial cells by using an Fc-tagged recombinant protein. CpClec-Fc displayed Ca(2+)-dependent, saturable binding to HCT-8 and Caco-2 cells and competitively inhibited C. parvum attachment to and infection of HCT-8 cells. Binding of CpClec-Fc was specifically inhibited by sulfated glycosaminoglycans, particularly heparin and heparan sulfate. Binding was reduced after the removal of heparan sulfate and following the inhibition of glycosaminoglycan synthesis or sulfation in HCT-8 cells. Like CpClec-Fc binding, C. parvum attachment to and infection of HCT-8 cells were inhibited by glycosaminoglycans and were reduced after heparan sulfate removal or inhibition of glycosaminoglycan synthesis or sulfation. Lastly, CpClec-Fc binding and C. parvum sporozoite attachment were significantly decreased in CHO cell mutants defective in glycosaminoglycan synthesis. Together, these results indicate that CpClec is a novel C-type lectin that mediates C. parvum attachment and infection via Ca(2+)-dependent binding to sulfated proteoglycans on intestinal epithelial cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26975991      PMCID: PMC4862729          DOI: 10.1128/IAI.01410-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

Review 2.  The C-type lectin-like domain superfamily.

Authors:  Alex N Zelensky; Jill E Gready
Journal:  FEBS J       Date:  2005-12       Impact factor: 5.542

3.  Cell surface heparan sulfate promotes replication of Toxoplasma gondii.

Authors:  Joseph R Bishop; Brett E Crawford; Jeffrey D Esko
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Use of glycan microarrays to explore specificity of glycan-binding proteins.

Authors:  David F Smith; Xuezheng Song; Richard D Cummings
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

5.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

6.  Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.

Authors:  Makoto Matsubayashi; Isao Teramoto-Kimata; Shigehiko Uni; Hyun S Lillehoj; Haruo Matsuda; Masaru Furuya; Hiroyuki Tani; Kazumi Sasai
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

7.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

8.  A comparative study on the heparin-binding proteomes of Toxoplasma gondii and Plasmodium falciparum.

Authors:  Yan Zhang; Ning Jiang; Boyin Jia; Zhiguang Chang; Yana Zhang; Xiaoyan Wei; Jianhua Zhou; Henan Wang; Xin Zhao; Shengchao Yu; Meng Song; Zhiwei Tu; Huijun Lu; Jigang Yin; Mats Wahlgren; Qijun Chen
Journal:  Proteomics       Date:  2014-07-03       Impact factor: 3.984

9.  Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion.

Authors:  Atsuko Inomata; Fumi Murakoshi; Akiko Ishiwa; Ryo Takano; Hitoshi Takemae; Tatsuki Sugi; Frances Cagayat Recuenco; Taisuke Horimoto; Kentaro Kato
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

10.  Analyses of interactions between heparin and the apical surface proteins of Plasmodium falciparum.

Authors:  Kyousuke Kobayashi; Ryo Takano; Hitoshi Takemae; Tatsuki Sugi; Akiko Ishiwa; Haiyan Gong; Frances C Recuenco; Tatsuya Iwanaga; Taisuke Horimoto; Hiroomi Akashi; Kentaro Kato
Journal:  Sci Rep       Date:  2013-11-11       Impact factor: 4.379

View more
  10 in total

1.  Comparative genomic analysis of the IId subtype family of Cryptosporidium parvum.

Authors:  Yaoyu Feng; Na Li; Dawn M Roellig; Alyssa Kelley; Guangyuan Liu; Said Amer; Kevin Tang; Longxian Zhang; Lihua Xiao
Journal:  Int J Parasitol       Date:  2017-02-10       Impact factor: 3.981

2.  Complete cryspovirus genome sequences from Cryptosporidium parvum isolate Iowa.

Authors:  Minh Vong; Jacob G Ludington; Honorine D Ward; Max L Nibert
Journal:  Arch Virol       Date:  2017-05-05       Impact factor: 2.574

3.  A novel C-type lectin from Trichinella spiralis mediates larval invasion of host intestinal epithelial cells.

Authors:  Hui Nan Hao; Yan Yan Song; Kai Ning Ma; Bo Ning Wang; Shao Rong Long; Ruo Dan Liu; Xi Zhang; Zhong Quan Wang; Jing Cui
Journal:  Vet Res       Date:  2022-10-18       Impact factor: 3.829

4.  A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition.

Authors:  Alexis R Gibson; Adam Sateriale; Jennifer E Dumaine; Julie B Engiles; Ryan D Pardy; Jodi A Gullicksrud; Keenan M O'Dea; John G Doench; Daniel P Beiting; Christopher A Hunter; Boris Striepen
Journal:  PLoS Pathog       Date:  2022-05-18       Impact factor: 7.464

5.  Preliminary Characterization of MEDLE-2, a Protein Potentially Involved in the Invasion of Cryptosporidium parvum.

Authors:  Baoling Li; Haizhen Wu; Na Li; Jiayuan Su; Ruilian Jia; Jianlin Jiang; Yaoyu Feng; Lihua Xiao
Journal:  Front Microbiol       Date:  2017-08-31       Impact factor: 5.640

6.  Identification and preliminary characterization of Hc-clec-160, a novel C-type lectin domain-containing gene of the strongylid nematode Haemonchus contortus.

Authors:  Ling Zhang; Lingyun Mou; Xueqiu Chen; Yi Yang; Min Hu; Xiangrui Li; Xun Suo; Xing-Quan Zhu; Aifang Du
Journal:  Parasit Vectors       Date:  2018-07-20       Impact factor: 3.876

7.  CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity.

Authors:  Carlos J Blondel; Joseph S Park; Troy P Hubbard; Alline R Pacheco; Carole J Kuehl; Michael J Walsh; Brigid M Davis; Benjamin E Gewurz; John G Doench; Matthew K Waldor
Journal:  Cell Host Microbe       Date:  2016-07-21       Impact factor: 21.023

8.  A Single-Pass Type I Membrane Protein from the Apicomplexan Parasite Cryptosporidium parvum with Nanomolar Binding Affinity to Host Cell Surface.

Authors:  Tianyu Zhang; Xin Gao; Dongqiang Wang; Jixue Zhao; Nan Zhang; Qiushi Li; Guan Zhu; Jigang Yin
Journal:  Microorganisms       Date:  2021-05-08

9.  Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages.

Authors:  Zeina Dagher; Shuying Xu; Paige E Negoro; Nida S Khan; Michael B Feldman; Jennifer L Reedy; Jenny M Tam; David B Sykes; Michael K Mansour
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

10.  The Oesophageal Squamous Cell Carcinoma Cell Line COLO-680N Fails to Support Sustained Cryptosporidium parvum Proliferation.

Authors:  Juan Vélez; Liliana M R Silva; Faustin Kamena; Arwid Daugschies; Sybille Mazurek; Anja Taubert; Carlos Hermosilla
Journal:  Pathogens       Date:  2021-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.